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Summary and Implications 
Aberrant migration of the deer meningeal worm, 
Parelaphostrongylus tenuis, is a commonly recognized 
cause of neurologic disease in South American camelids but 
is less frequently considered in other small ruminant 
species. After an unusually cool and wet summer season, 
central Iowa goat herds serviced by Iowa State University’s 
Veterinary Field Services have been increasingly affected 
by P. tenuis, with clinical cases presenting as early as 
August. Most caprine cases present with progressive 
neurologic deficits, starting with hind-end weakness and 
ataxia which may lead to complete paresis and death. Both 
sporadic cases and herd outbreaks involving as much as 
15% of the herd have been observed. These cases involve a 
range of ages from older pre-weaned kids (4-6 months) to 
mature animals. Herds browsing wooded areas with a high 
deer density appear to be especially at risk. Field diagnosis 
is based on exposure history, clinical presentation, 
cerebrospinal fluid analysis, and response to treatment. 
Treatment protocols include extra-label high-dose, extended 
course fenbendazole, anti-inflammatories, and supportive 
care along with single dose ivermectin for control of 
immature larvae. Ambulatory animals generally respond to 
treatment but may retain residual neurologic deficits; 
prognosis for downer animals is poor. Control effort may 
include restricting access to high-risk browse or grazing 
sites, exclusion of deer and mollusks, and 
chemoprophylaxis. 
 
Introduction 
While retrospective studies suggest that aberrant 
migration of the white-tailed deer meningeal worm, 
Parelaphostrongylus tenuis, is a relatively infrequent cause 
of spinal cord lesions in goats, it has become increasingly 
common in our clinical practice. P. tenuis is enzootic in the 
Iowa white-tailed deer (Odocoileus virginianus) population 
and the author has observed an uptick in presumptive and 
definitively diagnosed cases of meningeal worm among 
client herds. Anecdotal reports from producers suggest that 
other areas of the Upper Midwest are similarly affected. It 
appears that this year’s unseasonably cool and wet summer 
has contributed to both greater and earlier exposure to the 
parasite, especially for goats grazing woodland habitat. 
Under normal conditions, P. tenuis completes an indirect 
neurotropic life-cycle that passes between deer (definitive 
host) and a variety of terrestrial gastropods (intermediate 
host). This life-cycle typically takes four months to 
complete and little to no clinical disease is observed in 
infected deer.  
Goats and other accidental hosts become infected by 
ingesting infective L3 larvae present either in the snail or 
slug, or in the slime trail. Once ingested, normal larval 
maturation is disrupted, resulting in aberrant migration 
through the spinal cord and CNS. No eggs are produced, but 
the neural inflammation and parenchymal damage from 
aberrant migration causes clinical central nervous system 
disease with variable signs depending on the anatomic 
location of the lesions. Although intra-cranial deficits, upper 
motor-neuron, lower-motor neuron, and sensory deficits 
have all been described in a variety of species, in goats the 
most common signs include upper- and lower-motor neuron 
and peripheral limb sensory deficits.  
 
Clinical Presentation and Diagnostic Approach 
Given that the meningeal worm life cycle lasts four 
months in deer, that there is a forty-five to sixty day delay 
from infection to clinical disease in accidental hosts, and 
that mollusk activity declines during winter hibernation and 
mid-summer aestivation, most cases of meningeal worm 
present over the fall and winter season. This year, affected 
goats started showing signs of meningeal worm as early as 
the beginning of August, suggesting that the mollusks’ 
aestivation period was reduced by the moderate summer 
weather. On presentation, exposure to white-tailed deer was 
a common, though non-discriminating finding in the history 
and most cases had been exposed to substantial browse in 
wooded areas. Affected goats generally remained bright and 
alert with a good appetite and no fever; however, clients 
complained that the animal was lame, stiff, weak, ataxic, 
slow or reluctant to move, or unable to rise. The most 
consistent physical exam findings include asymmetric 
multi-focal neurologic disease with emphasis on pelvic limb 
deficits. Specific signs varied depending on the anatomic 
location of the lesions, but evidence of ataxia, hemi- or 
tetra-paresis, impaired proprioception, decreased 
nociception, and altered reflexes were common. Although 
asymmetric cranial nerve deficits (including facial paralysis 
and loss of menace reflex) have been reported in goats, they 
are less common than spinal lesion signs and were not 
observed in these cases. Clinical signs progressed over the 
course of several weeks, terminating in death or euthanasia 
for a minority of cases. Peritonitis and colic symptoms have 
been reported in goats after high-dose experimental 
infections but were not observed in these cases. P. tenuis 
associated linear pruritic dermatitis lesions have also been 
reported; several of these herds did have issues with focal 
hair loss and itching over the body or trunk but the pruitis 
and alopecia could not be definitively associated with 
meningeal worm infection.  
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Differentials for hemi-paretic cases included copper 
deficiency (enzootic ataxia, swayback), compressive lesions 
(vertebral malformation, trauma, abscess, or neoplasia), 
caprine arthritis-encephalomyelitis virus, and other putative 
viral causes of nonsuppurative meningoencephalomyelitis 
(such as rabies, pseudorabies, border disease, and 
theoretically West Nile virus). Presentations characterized 
by flaccidity or stiff, spastic movement and hyperreflexia 
could also be consistent with early stages of tetanus, 
laminitis, nutritional muscular dystrophy (vitamin E / 
selenium deficiency), polyradiculoneuritis, and myotonia 
congenita. Tetraparetic and terminal cases of caprine 
meningeal worm were differentiated from common causes 
of “downer” animals (polioencephalomalacia, listeriosis, 
pregnancy toxemia, and hypocalcemia) as well as less 
commonly etiologies (brainstem abscess, bacterial or viral 
meningoencephalitis, tick paralysis, organophosphate 
toxicity, and lidocaine toxicity). Rabies and scrapie are 
always considered on any open caprine neurologic case. 
Diagnosis of Parelaphostrongylus tenuis is currently 
complicated both by the lack of antemortem tests as well as 
difficulty in locating the parasite on necropsy. Presumptive 
antemortem diagnosis was made based on history of 
exposure to white-tailed deer habitat, clinical signs and CSF 
abnormalities, exclusion of other differentials, and response 
to treatment. CSF was collected by lumbosacral puncture 
from representative cases and consistently demonstrated a 
marked eosinophilic pleocytosis. When present, high levels 
of eosinophils in the CSF is a near-pathognomonic finding; 
unfortunately, in early cases the CSF may be normal or only 
demonstrate elevated monocyte counts, which is more 
commonly associated with listeriosis or viral meningitis. 
Standard CBC and serum chemistry profiles obtained from 
representative cases were largely unremarkable, which is 
typical for meningeal worm. Definitive diagnosis of 
Parelaphostrongylus tenuis spinal larval migrans was made 
through postmortem observation of relatively characteristic 
necrotic and/or eosinophilic inflammatory lesions associated 
with migration tracts and nematode segments in the spinal 
tissue sections. A nested PCR technique available at the 
University of Tennessee was been applied to formalin-fixed, 
paraffin-embedded tissues with success; this nPCR 
reportedly may work in the absence of visible parasite.  
 
Treatment, Prognosis, and Prevention 
Clinical therapy focused on three objectives: killing the 
parasite, reducing CNS tissue inflammation, and supporting 
vital functions. Treatment protocols included anthelminthic 
and anti-inflammatory medication along with ancillary 
supportive therapies and nursing care as clinically indicated; 
all drugs and doses used are extra-label in goats and must be 
administered under the advice of a veterinarian, with 
extended drug withdrawal intervals. Cases were treated with 
five days of high-dose oral fenbendazole (50 mg/kg), a 
single dose of ivermectin (0.4 mg/kg orally or 0.2 mg/kg 
SQ), and an anti-inflammatory (dexamethasone 0.1 mg/kg 
IM or flunixin meglumine 1-2 mg/kg IV). Additional 
recommended ancillary therapies could include parenteral 
administration of vitamin B or B-complex, vitamin E as a 
non-specific antioxidant, and fluid therapy. Attention to 
primary husbandry considerations included ensuring access 
to shelter, food, and water. Downer animals can benefit 
from ample bedding and physiotherapy to limit secondary 
pressure myopathy, compartment syndrome, formation of 
decubital lesions, and contracted tendons.   
Treatment prognosis is inconsistently dependent on 
severity of clinical signs at presentation; spontaneous 
recoveries have been reported. In general, recumbent 
animals and those exhibiting additional signs of depression 
or anorexia have a poorer prognosis for survival and require 
much more extensive supportive and nursing care. 
Ambulatory cases generally have a good to fair prognosis 
for survival and productivity, but progress is incremental. 
Neurologic deficits present six months or more after 
treatment are likely to be permanent. Of the cases that 
presented this year, most animals showed significant 
improvement and will be retained in the herds. 
Approximately 10% of the ambulatory cases died, were 
euthanized, or were culled for failure to improve enough to 
be productive in an extensive program.  
Meningeal worm prevention strategies can be grouped 
into chemoprophylaxis and management-centric options. 
Chemoprophylaxis with ivermectin or doramectin has been 
used prophylactically in high-risk camelids to kill the early 
larval stages before they access the CNS. When used in this 
manner, they are often administered monthly, year-round, 
but can be targeted seasonally in some climates; for 
example, in locations that experience significant hard 
freezes and hot, dry summers, 85% of meningeal worm 
exposure occurs from September to December. Routine 
chemoprophylaxis is not routinely recommended for goats, 
as it promotes anthelmintic resistance in common gastro-
intestinal nematodes such as Haemonchus contortus. While 
vaccine development efforts are underway, they are focused 
on alpacas and have not yet progressed to a conditionally-
available product. Although management strategies 
theoretically include excluding white-tailed deer and 
mollusks from the grazing areas through fencing, vegetative 
barriers, and/or mollusk control, as well as limiting 
livestock access to wet or marshy areas, on most operations 
it is effectively impossible to exclude deer or terrestrial 
gastropods from the goat pastures. Furthermore, applying 
copper sulfate molluscicides to pond perimeters will have 
little effect on dry-land or arboreal gastropods and will have 
ecological and animal health implications. In practice, some 
operations were able to restrict the goat’s access to known 
high-risk woodlands. Offset (“3D”) electric strand fencing 
was discussed as a relatively cost-effective solution for deer 
exclusion and guinea hens could be considered as a more 
environmentally-sustainable approach to snail and slug 
control; however, the specific efficacy of those interventions 
is not known.  
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